The global Vaccine Delivery Devices Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Device (Syringes, Jet Injectors, Others), By Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others).
The vaccine delivery devices market is witnessing significant growth in 2024, driven by the increasing focus on immunization programs, the development of novel vaccines, and advancements in vaccine delivery technology. Vaccine delivery devices include syringes, needle-free injectors, jet injectors, and microneedle patches, among others, designed to administer vaccines safely and effectively. With the global effort to combat infectious diseases and the emergence of new vaccination strategies, such as DNA vaccines and mRNA vaccines, there is a growing need for innovative vaccine delivery devices that can improve vaccine coverage, reduce needlestick injuries, and enhance patient compliance. With ongoing research and development in vaccine delivery technology, the market is expected to continue expanding, offering new opportunities for the prevention and control of infectious diseases worldwide.
A significant trend in the vaccine delivery devices market is the increasing focus on needle-free and self-administration devices. Traditional needle-based vaccine administration poses challenges such as needle phobia, needlestick injuries, and the need for trained healthcare professionals. Needle-free delivery systems, including jet injectors and microneedle patches, offer painless and user-friendly alternatives for vaccine administration, particularly in pediatric and adult populations. Moreover, self-administration devices empower individuals to administer vaccines at home or in community settings, promoting vaccination uptake and improving immunization coverage rates. This trend reflects the industry's commitment to enhancing vaccine delivery efficiency, patient comfort, and vaccination accessibility, driving market growth and innovation in vaccine delivery technologies.
The global immunization initiatives and pandemic preparedness efforts serve as significant drivers for the vaccine delivery devices market. Vaccination programs play a crucial role in preventing infectious diseases, reducing morbidity and mortality, and achieving public health goals worldwide. With the emergence of novel pathogens, such as the COVID-19 virus, and ongoing threats from vaccine-preventable diseases, there is an increased emphasis on vaccine development, distribution, and administration. Vaccine delivery devices, including syringes, autoinjectors, and nasal sprays, are essential tools in immunization campaigns, enabling safe and efficient vaccine delivery to individuals of all ages. As governments, international organizations, and healthcare providers prioritize vaccination strategies, the demand for vaccine delivery devices continues to grow, supporting market expansion and technological advancements.
The expansion into emerging markets represents a promising opportunity for growth within the vaccine delivery devices market. Emerging economies, particularly in Asia-Pacific, Latin America, and Africa, are witnessing rapid population growth, urbanization, and improvements in healthcare infrastructure. As these regions face infectious disease burdens and seek to strengthen immunization programs, there is a growing demand for vaccine delivery devices to support vaccination campaigns and routine immunization schedules. Additionally, rising awareness of vaccine-preventable diseases, expanding access to healthcare services, and government investments in public health contribute to market growth in emerging markets. Capitalizing on this opportunity requires manufacturers to develop cost-effective, culturally appropriate, and user-friendly vaccine delivery solutions tailored to the needs of diverse populations, as well as investment in distribution networks and local partnerships to effectively penetrate and serve emerging healthcare markets, thus expanding market reach and driving revenue growth in the evolving landscape of global immunization.
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
B. Braun Melsungen AG
Becton, Dickinson and Company
Carl-Zeiss-Stiftung
Enesi Pharma
Gerresheimer AG
Hindustan Syringes & Medical Devices Ltd
Mystic Pharmaceuticals Inc
PharmaJet Inc
Terumo Corp
Vaxxas
Zhejiang Longde Pharmaceutical Co. Ltd
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Vaccine Delivery Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Vaccine Delivery Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Vaccine Delivery Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Vaccine Delivery Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Vaccine Delivery Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Vaccine Delivery Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Vaccine Delivery Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Vaccine Delivery Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Vaccine Delivery Devices Industry
4.2 Key Market Trends in Vaccine Delivery Devices Industry
4.3 Potential Opportunities in Vaccine Delivery Devices Industry
4.4 Key Challenges in Vaccine Delivery Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Vaccine Delivery Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Vaccine Delivery Devices Market Outlook by Segments
7.1 Vaccine Delivery Devices Market Outlook by Segments, $ Million, 2021- 2030
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
8 North America Vaccine Delivery Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Vaccine Delivery Devices Markets in 2024
8.2 North America Vaccine Delivery Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Vaccine Delivery Devices Market size Outlook by Segments, 2021-2030
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
9 Europe Vaccine Delivery Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Vaccine Delivery Devices Markets in 2024
9.2 Europe Vaccine Delivery Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Vaccine Delivery Devices Market Size Outlook by Segments, 2021-2030
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
10 Asia Pacific Vaccine Delivery Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Vaccine Delivery Devices Markets in 2024
10.2 Asia Pacific Vaccine Delivery Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Vaccine Delivery Devices Market size Outlook by Segments, 2021-2030
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
11 South America Vaccine Delivery Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Vaccine Delivery Devices Markets in 2024
11.2 South America Vaccine Delivery Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Vaccine Delivery Devices Market size Outlook by Segments, 2021-2030
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
12 Middle East and Africa Vaccine Delivery Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Vaccine Delivery Devices Markets in 2024
12.2 Middle East and Africa Vaccine Delivery Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Vaccine Delivery Devices Market size Outlook by Segments, 2021-2030
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
B. Braun Melsungen AG
Becton, Dickinson and Company
Carl-Zeiss-Stiftung
Enesi Pharma
Gerresheimer AG
Hindustan Syringes & Medical Devices Ltd
Mystic Pharmaceuticals Inc
PharmaJet Inc
Terumo Corp
Vaxxas
Zhejiang Longde Pharmaceutical Co. Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Device
Syringes
Jet Injectors
Others
By Route of Administration
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
The global Vaccine Delivery Devices Market is one of the lucrative growth markets, poised to register a 7.9% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
B. Braun Melsungen AG, Becton, Dickinson and Company, Carl-Zeiss-Stiftung, Enesi Pharma, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd, Mystic Pharmaceuticals Inc, PharmaJet Inc, Terumo Corp, Vaxxas, Zhejiang Longde Pharmaceutical Co. Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume